These results are further corroborated by data obtained in humanized mice engrafted with a functional human immune system in which NASH development is accompanied by an expansion of CD4+ T-cells localized in the fibrotic regions and by an increased production of INF-γ and IL-17A. Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.